01-12-2024 | Solution-Focused Therapy | Review
The effectiveness of solution-focused therapy in cancer-related symptom management: a systematic review
Authors:
Maryam Maleki, Abbas Mardani, Mostafa Gholami, Nasrin Hanifi, Mojtaba Vaismoradi
Published in:
Supportive Care in Cancer
|
Issue 12/2024
Login to get access
Abstract
Objective
Solution-focused therapy (SFT) as a psychoeducational support intervention has gained an increasing attention for alleviating complications associated with cancer. The aim of this review was to integrate and synthesize scientific evidence regarding the efficacy of SFT in the management of cancer-related symptoms.
Methods
A systematic review was conducted, encompassing the exploration of five online databases—Web of Science, PubMed (including MEDLINE), CINAHL, Embase, and Scopus. Articles published from inception to December 2023 were retrieved. The review included all clinical trials and similar interventional studies assessing the impact of SFT on cancer-related symptoms. Relevant data were extracted from eligible studies following quality appraisals using appropriate methodological tools. The review results were presented in a narrative format due to the impossibility of conducting a meta-analysis.
Results
A total of 239 studies were identified during the search process, of which eight articles met the inclusion criteria. The overall sample size comprised 555 patients with cancer that were mostly female (n = 386). Four studies employed randomized controlled trials (RCT), while the remaining four utilized the non-RCT method. SFT-based interventions demonstrated effectiveness in addressing stress, anxiety, depression, somatization, cancer-related fatigue, pain catastrophizing, and negative coping. Additionally, they improved psychological well-being, hope, positive coping, self-efficacy, quality of life, and sexual quality of life among cancer patients.
Conclusions
Various SFT-based interventions have been shown to be effective in managing cancer-related symptoms and can be considered valuable additions to routine care, complementing medication therapy and other therapeutic measures to alleviate patients' suffering associated with cancer.
Systematic review registration number (PROSPERO): CRD42023413910.